FREE TOOL · LIVE DATA

TKPHF DCF Calculator

Run your own discounted cash flow valuation for Takeda Pharmaceutical Company Limited. The calculator is pre-filled with real data — $767.5B free cash flow (FY2025) and the live share price — so you only adjust the assumptions.

SEARCH STOCK

Search to auto-fill real company data

COMPANY DATA

Annual, in billions
$B
In billions
B
Per share
$

YOUR ASSUMPTIONS

Projected
%
Required return
%
yrs
Perpetuity
%

YOUR DCF RESULT

CALCULATED FAIR VALUE

$68.93

51.4% upsideUNDERVALUED

MARKET

$33.53

YOUR DCF

$68.93

MARGIN

$35.40

VALUE BREAKDOWN

PV of Projected Cash Flows$7675.1B
PV of Terminal Value
$10489.3B58% of total
Total Enterprise Value$18164.4B
÷ Shares Outstanding263.52B
Fair Value Per Share$68.93

SENSITIVITY CHECK

Try adjusting growth rate by ±2% and discount rate by ±1% to see how sensitive your fair value is to assumptions.

COMPARE WITH FPI FAIR VALUE

Your DCF reflects your assumptions. As an independent reference, here is Fair Price Index's daily blended fair value for Takeda Pharmaceutical Company Limited — DCF (50%), relative valuation (30%), and analyst consensus (20%):

See the full TKPHF valuation breakdown →

Frequently Asked Questions

What is TKPHF's free cash flow?

Takeda Pharmaceutical Company Limited generated $767.5 billion of free cash flow in fiscal year 2025. That figure is pre-filled in the calculator above and refreshed daily.

How do I calculate TKPHF's fair value with a DCF?

Project Takeda Pharmaceutical Company Limited's free cash flow forward at your assumed growth rate, discount each year back at your required return (WACC), add a terminal value, and divide by shares outstanding. The calculator above does all of this instantly as you adjust the assumptions.

What growth rate should I use for TKPHF?

Anchor on history and sector reality: look at Takeda Pharmaceutical Company Limited's revenue and cash flow growth over the past five to ten years, then ask what is sustainable going forward. Testing a conservative and an optimistic scenario matters more than any single number.

Is TKPHF undervalued right now?

That depends on the assumptions you feed the model — that is the point of running your own DCF. For an independent reference, Fair Price Index publishes a daily fair value for Takeda Pharmaceutical Company Limited blending DCF, relative valuation, and analyst consensus.

GET ALERTS

Track TKPHF's fair value daily

Download Fair Price Index and get notified when Takeda Pharmaceutical Company Limited's valuation shifts.

Download on the App StoreGet it on Google Play

Trusted by 500+ investors · Free tier available · PRO $2.99/month

RELATED

This calculator is for educational purposes only and does not constitute investment advice. Pre-filled figures come from the latest reported financials and may differ from other sources. Always verify against the company's filings.